Consolidated net income for the period of SEK 10,7 billion represents a strong improvement in the Group's financial position. The transformation into solely a transport vehicle group continued. The sale of most of the shareholding in Pharmacia & Upjohn yielded proceeds of SEK 12.9 billion and a capital gain of SEK 7.8 billion. The concentration process is thereby nearly completed.
Extensive efforts are under way in the Group within product development and in the production, marketing and distribution channels, measures which will create sustained profitability in line with Volvo's strategy.